|
Swiss Bridge is a private foundation associated with the Swiss Cancer League and the
International Union Against Cancer (UICC), and supports high quality cancer research in Europe (www.swissbridge.ch). Eligible for funding are projects dealing with basic cancer research, genetics or psycho-social research. Novel approaches to cancer therapy may also be supported. However, clinical trials are outside the scope of this year’s Swiss Bridge Award.
Scientists from academic and cancer research institutions in Europe are invited to submit a note of intent for a new cancer research project before March 30, 2007. The proposals will be screened by an international scientific board. The principal investigators of a shortlist of about 8 - 10 projects will then be invited to submit (by email) a detailed research application by the end of July 2007. Upon peer review and recommendation from the scientific board, up to five projects will receive funding amounting to a total support of up to 1 Million Swiss Francs. 50 percent of the funds available are earmarked by the donors for Swiss projects.
The note of intent should be no longer than 5 pages (2’500 words) and should include:
• the title of the project
• the name, address and affiliation of the principal investigator
• the project period (max. 3 years)
• the amount of financial support requested
• a summary of the project (max. 2 pages)
• a list of up to 12 publications by the principal investigator
• a statement regarding the relevance and potential contribution of the project to cancer control.
The note of intent must be transmitted by e-mail before March 30, 2007 to:
Office of the Scientific Board of the Swiss Bridge Foundation
c/o Swiss Cancer League, P.O. Box 8219, CH-3001 Bern, Switzerland
|
